Full Text:   <1957>

CLC number: R541.4

On-line Access: 

Received: 2002-08-28

Revision Accepted: 2002-12-10

Crosschecked: 0000-00-00

Cited: 4

Clicked: 4786

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE A 2003 Vol.4 No.3 P.369~373

http://doi.org/10.1631/jzus.2003.0369


Polymorphisms in the genes for coagulation factor II,V,VII in patients undergoing coronary angiography


Author(s):  XU Geng, JIN Guo-dong, FU Guo-sheng, MA Ji, SHAN Jiang, WANG Jia-nan

Affiliation(s):  The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China; more

Corresponding email(s):   xugengzju@21cn.com

Key Words:  Coagulation factor, Polymorphism, Coronary angiography, Myocardial infarction


Share this article to: More

XU Geng, JIN Guo-dong, FU Guo-sheng, MA Ji, SHAN Jiang, WANG Jia-nan. Polymorphisms in the genes for coagulation factor II,V,VII in patients undergoing coronary angiography[J]. Journal of Zhejiang University Science A, 2003, 4(3): 369~373.

@article{title="Polymorphisms in the genes for coagulation factor II,V,VII in patients undergoing coronary angiography",
author="XU Geng, JIN Guo-dong, FU Guo-sheng, MA Ji, SHAN Jiang, WANG Jia-nan",
journal="Journal of Zhejiang University Science A",
volume="4",
number="3",
pages="369~373",
year="2003",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.2003.0369"
}

%0 Journal Article
%T Polymorphisms in the genes for coagulation factor II,V,VII in patients undergoing coronary angiography
%A XU Geng
%A JIN Guo-dong
%A FU Guo-sheng
%A MA Ji
%A SHAN Jiang
%A WANG Jia-nan
%J Journal of Zhejiang University SCIENCE A
%V 4
%N 3
%P 369~373
%@ 1869-1951
%D 2003
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.2003.0369

TY - JOUR
T1 - Polymorphisms in the genes for coagulation factor II,V,VII in patients undergoing coronary angiography
A1 - XU Geng
A1 - JIN Guo-dong
A1 - FU Guo-sheng
A1 - MA Ji
A1 - SHAN Jiang
A1 - WANG Jia-nan
J0 - Journal of Zhejiang University Science A
VL - 4
IS - 3
SP - 369
EP - 373
%@ 1869-1951
Y1 - 2003
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.2003.0369


Abstract: 
Objective: To determine whether polymorphisms in the genes for coagulation factor II,V, VII could predispose an individual to increase risk for coronary artery disease (CAD) and/or myocardial infarction (MI) in Chinese. Methods: We screened coagulation factor II(G20210A), V(G1691A), VII (R353Q and HVR4) genotype in 374 patients undergoing coronary angiography by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) assay. Results: The R353Q and HVR4 genotype of the factor VII distribution was in accordance with Hardy-Weinberg equilibrium. The frequencies of FVII genotype or allele did not show statistically significant differences between CAD group and controls or between male and female. The frequencies of the Q allele and (RQ+QQ) genotype were significantly higher among the CAD patients without myocardial infarction (MI) history than among those with MI history (P<0.05). However, HVR4 polymorphism was not significantly different within groups. We only find one normal control of factorII(G20210A) mutation. No coagulation factor V(G1691A) mutation was found in the CAD patients and controls. Conclusion: The factor II(G20210A),V(G1691A) mutation is absent and may not be a major genetic factor for CAD and/or MI; the Q allele of the R353Q polymorphism of the factor VII gene may be a protective genetic factor against myocardial infarction in Chinese.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1]Bertina, R.M., Koeleman, P.C., Koster, T., Rosendaal, F.R.,Dirven, R.J., De Ronde, H., Velden, P.A. and Reitsma, P.H., 1994. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369:64-67.

[2]Feraresi, P., Machetti, C., Legnani, C., Cavallari, E., Castoldi, E., Mascoli, F., Ardissino, D., Palareti, E. and Bernardi, F., 1997. The heterozygous 20210 G/A prothrombin genotype is associated with early venous in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol, 17:2418-2422.

[3]Girelli, D., Russo, C. and Ferraresi, P., 2000. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med, 343: 774-780.

[4]Green, F.G., Kellecher, C., Wilkes, H., Temple, A., Meade, D. and Humphries, S., 1991. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb, 11: 540-546.

[5]Marchetti, G., Gemmati, D. and Patracchini, P., 1991. PCR detection of a repeat polymorphism within the F7 gene. Nucleic Acids Res, 19: 4570.

[6]Poort, S., Rosendaal, F.R., Reitsma, P.H. and Bertina, R., 1996. A common genetic variation in the 3'-untranslated region of the prothrombin levels and an increase in venous thrombosis. Blood, 88: 3698-3703.

[7]Redondo, H.H., Watzke, B., Stucki, I., Sulzer, F., Demarmels, Biasiutti, B.R., Binder, M., Furlan, B. and Lammle, W.A., 1999. Coagulation factor II, V, VII, and X, prothrombin gene 20210G→A transition, and factor V Leiden in coronary artery disease. Arterioscler Thromb Vasc Biol, 19:1020-1025.

[8]Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Stampfer, M.J., Eisenberg, P.R. and Miletich, J.P., 1995. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med, 332: 912-917.

[9]Ridker, P.M., Hennekens, C.H. and Miletich, J.P. 1999. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation, 99: 999-1004.

[10]Rosendaal, F.R., Siscovick, D.S., Schwartz, S.M., Psaty, M.Y., Raghunathan, T.E. and Vos, H.L., 1997. A common prothrombin variant (20210 G to A) increase the risk of myocardial infarction in young women. Blood, 90: 1747-1750.

[11]Song, J., Yoon, Y.M. and Jung, H.J., 2000. Plasminogen activator inhibitor-1 4G/5G promoter polymorphism in Kroean patients with coronary artery disease. J. Kroean Med Sci., 15(2):146-152.

[12]Watzke, H.H., Schuttrumpf, J., Graf, S., Huber, K. and Panzer, S., 1997. Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease. Thromb Res, 87: 521-526.

[13]Wu, A.H. And Tsongalis, G.J., 2001. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular disease. Am J. Cardiol, 87:1361-1366

Open peer comments: Debate/Discuss/Question/Opinion

<1>

munsoor@university of sudan<mun.2000@yahoo.com>

2010-08-17 17:31:13

wanted this article to get the genotyping procedure thanks

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - Journal of Zhejiang University-SCIENCE